Learn more at LeadIQ.com

Insights

Expansion of Leadership Team Inozyme Pharma has been actively expanding its leadership team by hiring experienced individuals like Erik Harris, Ruth du Moulin, and Soojin Kim. These additions indicate a focus on building a strong team to drive growth and development.

Public Offering of Common Stock The recent public offering of common stock by Inozyme Pharma presents an opportunity for sales professionals to engage with potential investors and stakeholders interested in the company's vision and products. This can lead to new partnerships and collaborations.

Investment from Denali Advisors The investment of $149,000 by Denali Advisors into Inozyme Pharma signifies a vote of confidence in the company's potential. This presents a chance for sales development representatives to explore partnerships or collaborations with Denali Advisors and potentially other investors in the future.

Focus on Rare Diseases Inozyme Pharma's focus on developing therapeutics for rare diseases related to bone health and blood vessel function creates a niche market opportunity. Sales professionals can leverage this unique positioning to target healthcare providers, patient advocacy groups, and regulatory bodies in the rare disease space.

Technology Stack Utilization By utilizing a tech stack that includes Google Analytics, WordPress, Cloudflare, and more, Inozyme Pharma demonstrates a commitment to leveraging technology for enhanced operations and reach. Sales development representatives can leverage the company's tech-savvy approach to enhance customer engagement and outreach.

Similar companies to Inozyme Pharma

Inozyme Pharma Tech Stack

Inozyme Pharma uses 8 technology products and services including Google Analytics, WordPress, Cloudflare, and more. Explore Inozyme Pharma's tech stack below.

Google Analytics
Analytics
WordPress
Content Management System
Cloudflare
Content Management System
Twitter Emoji (Twemoji)
Font Scripts
Typekit
Font Scripts
jQuery-pjax
Mobile Frameworks
Elementor
Page Builders
Lua
Programming Languages

Media & News

Inozyme Pharma's Email Address Formats

Inozyme Pharma uses at least 1 format(s):

Inozyme Pharma Email Formats	Example	Percentage
First.Last@inozyme.com	John.Doe@inozyme.com	49%
First@inozyme.com	John@inozyme.com	1%
First.Last@inozyme.com	John.Doe@inozyme.com	49%
First@inozyme.com	John@inozyme.com	1%

Frequently Asked Questions

Where is Inozyme Pharma's headquarters located?

Inozyme Pharma's main headquarters is located at 321 Summer St Suite 400 Boston, Massachusetts 02210 US. The company has employees across 1 continents, including North America.

What is Inozyme Pharma's phone number?

You can contact Inozyme Pharma's main corporate office by phone at

+1-857-330-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Inozyme Pharma's stock symbol?

Inozyme Pharma is a publicly traded company; the company's stock symbol is INZY.

What is Inozyme Pharma's official website and social media links?

Inozyme Pharma's official website is inozyme.com and has social profiles on LinkedIn.

How much revenue does Inozyme Pharma generate?

As of September 2024, Inozyme Pharma's annual revenue reached $15M.

What is Inozyme Pharma's SIC code NAICS code?

Inozyme Pharma's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Inozyme Pharma have currently?

As of September 2024, Inozyme Pharma has approximately 74 employees across 1 continents, including North America. Key team members include Chief Financial Officer: S. S.Chief Scientific Officer: Y. S.Vice President Worldwide Clinical Operations & Site Strategy: A. B.. Explore Inozyme Pharma's employee directory with LeadIQ.

What industry does Inozyme Pharma belong to?

Inozyme Pharma operates in the Biotechnology Research industry.

What technology does Inozyme Pharma use?

Inozyme Pharma's tech stack includes Google AnalyticsWordPressCloudflareTwitter Emoji (Twemoji)TypekitjQuery-pjaxElementorLua.

What is Inozyme Pharma's email format?

Inozyme Pharma's email format typically follows the pattern of . Find more Inozyme Pharma email formats with LeadIQ.

How much funding has Inozyme Pharma raised to date?

As of September 2024, Inozyme Pharma has raised $60M in funding. The last funding round occurred on Jul 27, 2023 for $60M.

When was Inozyme Pharma founded?

Inozyme Pharma was founded in 2016.

Inozyme Pharma

Inozyme Pharma

Biotechnology ResearchMassachusetts, United States51-200 Employees

We are a pioneering, clinical-stage biopharmaceutical company dedicated to developing innovative therapeutics for rare diseases that affect bone health and blood vessel function. Our lead candidate, INZ-701, is an ENPP1 Fc fusion protein enzyme replacement therapy (ERT) designed to increase PPi and adenosine, enabling the potential treatment of multiple diseases caused by deficiencies in these metabolites. By targeting the PPi-Adenosine Pathway, INZ-701 aims to correct pathological mineralization and intimal proliferation, addressing the significant morbidity and mortality in these devastating diseases. It is currently in clinical development for the treatment of ENPP1 Deficiency, ABCC6 Deficiency, and calciphylaxis.

Company Overview

Headquarters: 321 Summer St Suite 400 Boston, Massachusetts 02210 US
Phone number: ✕
Access Insights for Inozyme Pharma and Millions of Other Companies
Sign up for full access to Inozyme Pharma information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
+1-857-330-****
Website: inozyme.com
SIC Code: 8733 - Noncommercial Research Organizations
Stock Symbol: INZY
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded: 2016
Employees: 51-200

Media & News

Funding & Financials

$60M
Inozyme Pharma has raised a total of $60M of funding over 6 rounds. Their latest funding round was raised on Jul 27, 2023 in the amount of $60M.
$10M$50M
Inozyme Pharma's revenue is in the range of $10M$50M

Funding & Financials

$60M
Inozyme Pharma has raised a total of $60M of funding over 6 rounds. Their latest funding round was raised on Jul 27, 2023 in the amount of $60M.
$10M$50M
Inozyme Pharma's revenue is in the range of $10M$50M

Company Leadership

S. S.
Chief Financial Officer
✕
Access Insights for Inozyme Pharma and Millions of Other Companies
Sign up for full access to Inozyme Pharma information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Inozyme Pharma and Millions of Other Companies
Sign up for full access to Inozyme Pharma information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
Y. S.
Chief Scientific Officer
✕
Access Insights for Inozyme Pharma and Millions of Other Companies
Sign up for full access to Inozyme Pharma information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Inozyme Pharma and Millions of Other Companies
Sign up for full access to Inozyme Pharma information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
A. B.
Vice President Worldwide Clinical Operations & Site Strategy
✕
Access Insights for Inozyme Pharma and Millions of Other Companies
Sign up for full access to Inozyme Pharma information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Inozyme Pharma and Millions of Other Companies
Sign up for full access to Inozyme Pharma information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
L. B.
Vice President Clinical Operations
✕
Access Insights for Inozyme Pharma and Millions of Other Companies
Sign up for full access to Inozyme Pharma information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Inozyme Pharma and Millions of Other Companies
Sign up for full access to Inozyme Pharma information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
M. M.
Head Regulatory Operations
✕
Access Insights for Inozyme Pharma and Millions of Other Companies
Sign up for full access to Inozyme Pharma information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Inozyme Pharma and Millions of Other Companies
Sign up for full access to Inozyme Pharma information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Employee Directory

D. W.
Senior Vice President And Chief Medical Officer
✕
Access Insights for Inozyme Pharma and Millions of Other Companies
Sign up for full access to Inozyme Pharma information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Inozyme Pharma and Millions of Other Companies
Sign up for full access to Inozyme Pharma information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
S. K.
Svp | Chief Technical Operations Officer
✕
Access Insights for Inozyme Pharma and Millions of Other Companies
Sign up for full access to Inozyme Pharma information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Inozyme Pharma and Millions of Other Companies
Sign up for full access to Inozyme Pharma information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
D. S.
Vice President, Toxicology
✕
Access Insights for Inozyme Pharma and Millions of Other Companies
Sign up for full access to Inozyme Pharma information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Inozyme Pharma and Millions of Other Companies
Sign up for full access to Inozyme Pharma information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
C. N.
Senior Vice President Hcp And Patient Engagement
✕
Access Insights for Inozyme Pharma and Millions of Other Companies
Sign up for full access to Inozyme Pharma information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Inozyme Pharma and Millions of Other Companies
Sign up for full access to Inozyme Pharma information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
S. B. O.
Vice President, Head Of Program Management
✕
Access Insights for Inozyme Pharma and Millions of Other Companies
Sign up for full access to Inozyme Pharma information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Inozyme Pharma and Millions of Other Companies
Sign up for full access to Inozyme Pharma information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Go to Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.